Literature DB >> 31943071

Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure.

Yumeng Z McDaniel1,2, Dake Wang2,3, Robin P Love4, Madison B Adolph4, Nazanin Mohammadzadeh4, Linda Chelico4, Louis M Mansky1,2,3,5,6,7.   

Abstract

The human apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 (APOBEC3, A3) family member proteins can deaminate cytosines in single-strand (ss) DNA, which restricts human immunodeficiency virus type 1 (HIV-1), retrotransposons, and other viruses such as hepatitis B virus, but can cause a mutator phenotype in many cancers. While structural information exists for several A3 proteins, the precise details regarding deamination target selection are not fully understood. Here, we report the first parallel, comparative analysis of site selection of A3 deamination using six of the seven purified A3 member enzymes, oligonucleotides having 5'TC3' or 5'CT3' dinucleotide target sites, and different flanking bases within diverse DNA secondary structures. A3A, A3F and A3H were observed to have strong preferences toward the TC target flanked by A or T, while all examined A3 proteins did not show a preference for a TC target flanked by a G. We observed that the TC target was strongly preferred in ssDNA regions rather than dsDNA, loop or bulge regions, with flanking bases influencing the degree of preference. CT was also shown to be a potential deamination target. Taken together, our observations provide new insights into A3 enzyme target site selection and how A3 mutagenesis impacts mutation rates.
© The Author(s) 2020. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31943071      PMCID: PMC7026630          DOI: 10.1093/nar/gkz1164

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  78 in total

1.  Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.

Authors:  Rupert C L Beale; Svend K Petersen-Mahrt; Ian N Watt; Reuben S Harris; Cristina Rada; Michael S Neuberger
Journal:  J Mol Biol       Date:  2004-03-26       Impact factor: 5.469

Review 2.  Retroviral restriction by APOBEC proteins.

Authors:  Reuben S Harris; Mark T Liddament
Journal:  Nat Rev Immunol       Date:  2004-11       Impact factor: 53.106

3.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.

Authors:  F Dyda; A B Hickman; T M Jenkins; A Engelman; R Craigie; D R Davies
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

4.  Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase.

Authors:  J A Peliska; S J Benkovic
Journal:  Science       Date:  1992-11-13       Impact factor: 47.728

5.  APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells.

Authors:  Jenny L Anderson; Thomas J Hope
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

Review 6.  Fifty years of DNA "breathing": Reflections on old and new approaches.

Authors:  Peter H von Hippel; Neil P Johnson; Andrew H Marcus
Journal:  Biopolymers       Date:  2013-12       Impact factor: 2.505

7.  APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure.

Authors:  Colleen M Holtz; Holly A Sadler; Louis M Mansky
Journal:  Nucleic Acids Res       Date:  2013-04-24       Impact factor: 16.971

8.  Crystal structures of APOBEC3G N-domain alone and its complex with DNA.

Authors:  Xiao Xiao; Shu-Xing Li; Hanjing Yang; Xiaojiang S Chen
Journal:  Nat Commun       Date:  2016-08-02       Impact factor: 14.919

9.  Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.

Authors:  Atanu Maiti; Wazo Myint; Tapan Kanai; Krista Delviks-Frankenberry; Christina Sierra Rodriguez; Vinay K Pathak; Celia A Schiffer; Hiroshi Matsuo
Journal:  Nat Commun       Date:  2018-06-25       Impact factor: 14.919

Review 10.  A Novel Regulator of Activation-Induced Cytidine Deaminase/APOBECs in Immunity and Cancer: Schrödinger's CATalytic Pocket.

Authors:  Justin J King; Mani Larijani
Journal:  Front Immunol       Date:  2017-04-06       Impact factor: 7.561

View more
  12 in total

1.  Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2.

Authors:  Morgan E Meissner; Nora A Willkomm; Jamie Lucas; William G Arndt; Sarah F Aitken; Emily J Julik; Sunanda Baliga; Louis M Mansky
Journal:  J Mol Biol       Date:  2021-11-10       Impact factor: 5.469

2.  Molecular Biology and Diversification of Human Retroviruses.

Authors:  Morgan E Meissner; Nathaniel Talledge; Louis M Mansky
Journal:  Front Virol       Date:  2022-06-02

3.  Infection of Bronchial Epithelial Cells by the Human Adenoviruses A12, B3, and C2 Differently Regulates the Innate Antiviral Effector APOBEC3B.

Authors:  Noémie Lejeune; Florian Poulain; Kévin Willemart; Zoé Blockx; Sarah Mathieu; Nicolas A Gillet
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

4.  Mutational pressure by host APOBEC3s more strongly affects genes expressed early in the lytic phase of herpes simplex virus-1 (HSV-1) and human polyomavirus (HPyV) infection.

Authors:  Maxwell Shapiro; Laurie T Krug; Thomas MacCarthy
Journal:  PLoS Pathog       Date:  2021-04-30       Impact factor: 6.823

5.  Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.

Authors:  P Simmonds
Journal:  mSphere       Date:  2020-06-24       Impact factor: 4.389

6.  Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK-directed activation of NF-κB.

Authors:  Manikandan Periyasamy; Anup K Singh; Carolina Gemma; Raed Farzan; Rebecca C Allsopp; Jacqueline A Shaw; Sara Charmsaz; Leonie S Young; Paula Cunnea; R Charles Coombes; Balázs Győrffy; Lakjaya Buluwela; Simak Ali
Journal:  Oncogene       Date:  2020-12-15       Impact factor: 9.867

7.  Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.

Authors:  Jeremy Ratcliff; Peter Simmonds
Journal:  Virology       Date:  2021-01-07       Impact factor: 3.616

Review 8.  Deaminase-Independent Mode of Antiretroviral Action in Human and Mouse APOBEC3 Proteins.

Authors:  Yoshiyuki Hakata; Masaaki Miyazawa
Journal:  Microorganisms       Date:  2020-12-12

9.  Coronavirus genomes carry the signatures of their habitats.

Authors:  Yulong Wei; Jordan R Silke; Parisa Aris; Xuhua Xia
Journal:  PLoS One       Date:  2020-12-22       Impact factor: 3.240

10.  The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense.

Authors:  Cem Azgari; Zeynep Kilinc; Berk Turhan; Defne Circi; Ogun Adebali
Journal:  Viruses       Date:  2021-03-02       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.